# Ollin Bio

**Canonical:** https://apis.io/providers/ollin-bio/  
**Website:** https://ollin.bio/  
**APIs profiled:** 0

Ollin Bio is a privately held biotechnology company developing novel therapeutics, organizing its work around defined therapeutic areas and a product pipeline of drug candidates in development. Backed by a16z, the company was added to the API Evangelist network as a portfolio-company lead. As a research-stage therapeutics company, Ollin Bio publishes a marketing and corporate website but does not expose a public developer program, API, documentation, or SDKs at this time. This profile records the company's public identity and web properties; it will be re-enriched if a public API surface ever appears.

## Kin Score — 9.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Ollin Bio Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Therapeutics, Life Sciences, Drug Development, Pharmaceuticals, a16z Portfolio

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/ollin-bio/). Scores are computed from the provider's own public artifacts under a published rubric.